BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 30988064)

  • 1. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
    Banday MZ; Sameer AS; Chowdri NA; Haq E
    Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-α (TNF-α)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population - A case control study in a detailed perspective.
    Banday MZ; Balkhi HM; Hamid Z; Sameer AS; Chowdri NA; Haq E
    Meta Gene; 2016 Sep; 9():128-36. PubMed ID: 27331018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of TIMP2-418G/C and MMP9-1562C/T variants on the male infertility risk.
    Roshankhah S; Mansouri K; Bakhtiari M; Salahshoor MR; Asgari R
    Mol Biol Rep; 2019 Feb; 46(1):861-866. PubMed ID: 30515695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
    Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
    Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
    Srivastava P; Lone TA; Kapoor R; Mittal RD
    Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation and Ile105val polymorphism of
    Nissar S; Sameer AS; Rasool R; Chowdri NA; Rashid F
    Indian J Cancer; 2019; 56(3):248-253. PubMed ID: 31389389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of TIMP2/TIMP3 genes on the risk of osteosarcoma in Zhejiang population.
    Wu Z; Chen H; Pan L; Yu W; Lou C; Chen J; He D
    Medicine (Baltimore); 2021 Mar; 100(11):e24818. PubMed ID: 33725949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
    Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
    Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-2, -3 and TIMP-2, -3 polymorphisms in colorectal cancer in a Chinese Han population: A case-control study.
    Wang N; Zhou S; Fang XC; Gao P; Qiao Q; Wu T; He XL
    Gene; 2020 Mar; 730():144320. PubMed ID: 31887330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Liao WC; Huang CW; Hsia TC; Shen YC; Chang WS; Tsai CW; Wang YC; Yin MC; Bau DT
    Anticancer Res; 2021 Nov; 41(11):5425-5430. PubMed ID: 34732411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
    Yang Y; Huang F; Wu X; Huang C; Li Y
    Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
    Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic investigation of the relationship between high myopia and polymorphisms of the MMP2, TIMP2, and TIMP3 genes by a DNA pooling approach.
    Leung KH; Yiu WC; Yap MK; Ng PW; Fung WY; Sham PC; Yip SP
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3893-900. PubMed ID: 21421877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.